About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Minneapolis | 170 Studies

Clinical Trials Ovarian CancerMinneapolis

Ovarian Cancer Clinical Trials in Minneapolis

Find 170 clinical trials for ovarian cancer near Minneapolis, Minnesota. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Minneapolis

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 170 trials

CompletedAssessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2Lung cancer is the leading cause of cancer death in the United States. Currently it remains impossible to predict which smokers will get cancer.NCT00158145·Minneapolis, Minnesota WithdrawnEfficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.This study will assess the effect of IT-101 on delaying cancer progression in patients with platinum sensitive ovarian cancer.NCT00753740·Decatur, Illinois and 6 others RecruitingPhase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal CancerThis is a randomized, adaptive, open label, multicenter trial to evaluate the safety and efficacy of intraperitoneal (IP) IMNN-001 plus chemotherapy compared to chemotherapy alone.NCT06915025·Orlando, Florida and 9 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedCarboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003644·Birmingham, Alabama and 150 others

Active not recruitingRoll Over StudY for Patients Who Have Completed a Previous Oncology Study With OlaparibThe rationale of the ROSY-O study is to continue to provide study treatment for patients who have participated in a parent study with olaparib and who are continuing to derive…NCT04421963·Boca Raton, Florida and 106 others

Active not recruitingTreatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With CancerThis trial studies treatment effects on development of chemotherapy-induced peripheral neuropathy in patients with cancer.NCT03939481·Antioch, California and 168 others

TerminatedTopotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005029·Birmingham, Alabama and 73 others

RecruitingA Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid TumorsThis study is being done to find out of NRM-823 is safe and can treat participants with locally advanced or metastatic solid tumors.NCT07182149·Denver, Colorado and 17 others

CompletedAllogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast CancerThis is a single center phase II trial designed to optimize a clinical platform of lymphodepleting chemotherapy and T-cell suppression to promote the persistence, function, and…NCT01105650·Minneapolis, Minnesota

CompletedZoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell TransplantRATIONALE: Zoledronic acid, vitamin D, and calcium may prevent bone loss in patients who are undergoing donor stem cell transplant.NCT00321932·Minneapolis, Minnesota and 1 other

CompletedStudy of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal CarcinomaPhase I will determine the MTD and evaluated the safety profile of oral lenalidomide on days 1-14 when given with topotecan on days 1-5 of every 21 day cycle Phase II will…NCT00179712·Augusta, Georgia and 2 others

RecruitingRelacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersThis is a Phase 2, open-label, global, multi-arm study to evaluate efficacy and safety of relacorilant in combination with other treatments in patients with gynecological cancers.NCT06906341·Birmingham, Alabama and 48 others

CompletedLaparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal CancersRATIONALE: Laparoscopic staging may help doctors plan more effective treatment for ovarian, primary fallopian tube, and primary abdominal cancers.NCT00002538·Los Angeles, California and 10 others

RecruitingUNTOLD Ovarian Cancer Unmet Needs SurveyThe goal of this study is to comprehensively measure ongoing concerns and unmet needs of individuals living with ovarian cancer.NCT07070726·Minneapolis, Minnesota

RecruitingA Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 OverexpressionThis study will evaluate the safety and efficacy of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer (PROC) With Cyclin E1 Overexpression.NCT07023627·Mobile, Alabama and 73 others

RecruitingStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab AdizutecanCancer is a condition where cells in a specific part of body grow and reproduce uncontrollably.NCT05005403·Duarte, California and 47 others

TerminatedStudy to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian CancerThis is an open-label, single-arm Phase 2 study to evaluate the efficacy and safety of combination of niraparib and dostarlimab (TSR-042) in participants with advanced, relapsed…NCT03955471·Scottsdale, Arizona and 26 others

TerminatedDocetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004037·Birmingham, Alabama and 66 others

RecruitingTesting Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial CarcinomaThis phase II trial tests whether the combination of nivolumab and ipilimumab is better than nivolumab alone to shrink tumors in patients with deficient mismatch repair system…NCT05112601·Birmingham, Alabama and 137 others

Active not recruitingA Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS MutationThis study will assess the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian Cancer…NCT04625270·Scottsdale, Arizona and 46 others

PreviousPage 4 of 9Next

Other Conditions in Minneapolis

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia